US court backs federal embryonic stem cells funds

WASHINGTON,  (Reuters) – A U.S. appeals court ruled  on Friday the Obama administration can continue using federal  money to fund human embryonic stem cell research, a possible  avenue toward new treatments for many medical conditions.

The appeals court overturned a ruling by a federal judge  who found that the U.S. National Institutes of Health (NIH)  guidelines on such research violated the law because embryos  were destroyed and it put other researchers working with adult  stem cells at a disadvantage to win federal grants.

Opponents of human embryonic stem cell research, including  many religious conservatives, argue that it is unacceptable  because it destroys human embryos.

Such stem cells come from days-old human embryos and can  produce any type of cell in the body. Scientists hope to be  able to use them to address spinal cord injuries, cancer,  diabetes and diseases such as Alzheimer’s and Parkinson’s.

U.S. District Judge Royce Lamberth last August blocked the  taxpayer funding. His decision was put on hold pending appeal  so federal money continued to flow after the White House warned  research costing millions of dollars would be lost if halted.